Related Experiment Video
Updated: Jun 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Use of cardio-ankle vascular index in chronic dialysis patients
Tsu-Wang Shen1, Chih-Hsien Wang, Yu-Hsien Lai
1Department of Medical Informatics, Medical College, Tzu Chi University, Hualien, Taiwan.
Insights
In dialysis patients, developing new arterial stiffness over one year was linked to being older and having higher initial serum phosphorus levels. These factors are key indicators for increased cardiovascular risk in this population.
Area of Science:
- Cardiovascular Health
- Nephrology
- Vascular Biology
Background:
- Arterial stiffness predicts mortality, especially in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.
- Identifying de novo arterial stiffness risk factors in long-term dialysis is crucial for patient outcomes.
Purpose of the Study:
- To identify risk factors for developing new arterial stiffness (de novo arterial stiffness) in patients undergoing long-term dialysis.
Main Methods:
- A one-year prospective study of 59 dialysis patients without initial arterial stiffness.
- Cardio-ankle vascular index (CAVI) measured at baseline and 1 year; de novo arterial stiffness defined as CAVI ≥ 9.
- Analysis of baseline and final laboratory parameters and patient characteristics.
Main Results:
- Patients who developed de novo arterial stiffness were significantly older.
- Higher initial serum phosphorus and calcium × phosphorus product were observed in patients with de novo arterial stiffness.
- Lower initial hematocrit was associated with de novo arterial stiffness.
Conclusions:
- Age and elevated initial serum phosphorus are independent risk factors for developing de novo arterial stiffness in dialysis patients.
- These findings highlight the importance of monitoring and managing these factors to mitigate cardiovascular risk in ESRD patients.
Background:
Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality, particularly in patients with chronic kidney disease and end-stage renal disease (ESRD). The objective of this study was to determine the risk factors for de novo arterial stiffness in long-term dialysis patients.
Materials And Methods:
A total of 59 dialysis patients without initial arterial stiffness were studied for 1 year. Cardio-ankle vascular index (CAVI) was measured and a CAVI value ≥ 9 at the end of 1 year was defined as de novo arterial stiffness. The initial baseline characteristics and laboratory parameters and final laboratory parameters after 1 year were analysed.
Results:
Dialysis patients with de novo arterial stiffness were significantly older than dialysis patients without de novo arterial stiffness. Initial serum phosphorus and calcium × phosphorus product of dialysis patients with de novo arterial stiffness were significantly greater than those of dialysis patients without de novo arterial stiffness. The haematocrit of dialysis patients with de novo arterial stiffness was significantly lower than that of dialysis patients without de novo arterial stiffness. Multivariate logistic regression analysis showed that age and initial serum phosphorus were independent risk factors for de novo arterial stiffness in dialysis patients.
Conclusion:
After 1-year follow-up, de novo arterial stiffness in dialysis patients as determined by CAVI was significantly associated with age and initial serum phosphorus.
Related Concept Videos
Hemodialysis I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies VII: Vascular Imaging

